US economy, Indian rupee and more... - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

US economy, Indian rupee and more...

May 7, 2008

US economy sinking
While talks about the US economy sinking into a recession have been doing the rounds for quite some while now, latest economic reports released seem to suggest that the economy, though tethering on the edge, is managing to hold on. While the Federal Reserve has cut interest rates to 2%, there is a possibility that there could be a pause in any further cuts given that inflation induced by rising oil and food prices refuses to abate soon. The Economist states that as per the initial GDP estimates, output grew at an annualised rate of 0.6% in the period January to March 2008, which was higher than estimates. The weaker dollar, also, to a certain extent has helped matters. US companies deriving revenues from overseas markets are enjoying the fruits of a rise in profitability. In fact, as per the magazine, excluding oil, America's current account deficit has shrunk to an eight year low of 2.4% of GDP. Besides this, for the first time in the last four months, the non-farm payrolls has shown only 20,000 job cuts as against the forecasted drop of 75,000. All these factors sparked a rally in the dollar, which has received a battering in the past one year.

  • Is the US economy on thin ice?

    Indian Rupee depreciating
    The Indian rupee has gradually depreciated to Rs 40.58 per US dollar prompted by the rise in the greenback and the pressure on the currency towards the end of the month when oil importers look to make payments. The other factor, which has been weighing heavy on the rupee, is the burgeoning trade deficit, which widened to US$ 72.5 bn during the period April 2007 to February 2008, reflecting a 47% YoY growth. Sharp rise in the non-oil imports has resulted in India's overall imports growing faster than exports during 2007-08. Having said that, robust 39% YoY growth in invisibles (trade in services, transfers and income from overseas assets) ensured that the current account deficit was capped at US$ 16 bn.

  • What makes the rupee weak?

    Downside of R&D in Pharma
    A leading business daily reported that India's second largest pharma company, Dr. Reddy's has discontinued R&D on its cardiovascular drug. This drug was part of the four compounds that were transferred to Perlecan Pharma, an integrated drug development company formed by Dr. Reddy's in FY06. One other molecule focusing on the therapeutic area of diabetes has also been discontinued, which effectively means that Perlecan now has two molecules as compared to the four that it had started out with. While Dr. Reddy's lead molecule 'Balaglitazone' has been progressing well in clinical trials, it belongs to a class of drugs which have faced safety issues in the past prompting the US FDA to be more stringent while approving these drugs. Case in point is GSK Plc's anti-diabetic drug 'Avandia', which was reported to increase the rate of heart attacks.

    These developments highlight the risks and uncertainty associated with R&D, which though when successful can enhance revenues and profits, can also dampen profitability when a particular drug fails to advance further in clinical trials. It may be noted that besides Dr. Reddy's, other domestic companies such as Sun Pharma, Nicholas Piramal, Ranbaxy and Wockhardt have also hived off their R&D units into separate companies. What separates Dr. Reddy's from its peers is the fact that the former has roped in private capital from Citigroup and ICICI Ventures, while the others are planning to list the hived off R&D entities on the Indian bourses. Whether this development will push Dr. Reddy's to mirror the strategy of its peers remains to be seen.

  • Equitymaster requests your view! Post a comment on "US economy, Indian rupee and more...". Click here!


    More Views on News

    The Top 6 Artificial Intelligence Plays in India (Views On News)

    Dec 6, 2021

    Investors looking to tap into AI theme need to keep an eye on tech firm leveraging the power of AI are making things possible.

    6 Penny Stocks that Rallied 1,000%+ in One Year (Views On News)

    Dec 6, 2021

    These penny stocks shed their penny status by surging 1,000% or more in the last one year.

    6 Popular Stocks that Turned into Penny Stocks (Views On News)

    Nov 27, 2021

    A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

    All You Need to Know about the Newly Launched Bharat Bond ETF 2032 (Outside View)

    Dec 7, 2021

    Bharat Bond ETF - 2032 is a new fund offer that will follow a buy-and-hold investment strategy tracking the constituents of Nifty Bharat Bond - April 2032 index.

    Stocks You Should Buy, Even if the Market Falls (Profit Hunter)

    Dec 7, 2021

    Here is how to approach smallcap investing as markets get nervous.

    More Views on News

    Most Popular

    Infosys vs TCS: Which is Better? (Views On News)

    Nov 26, 2021

    In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

    This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

    Nov 24, 2021

    Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

    6 Popular Stocks that Turned into Penny Stocks (Views On News)

    Nov 27, 2021

    A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

    India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

    Nov 30, 2021

    These 5 companies dominate their sectors with a huge piece of the pie.

    The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

    Nov 26, 2021

    How India's EV transition could be a major headwind for the incumbents.


    Become A Smarter Investor
    In Just 5 Minutes

    Multibagger Stock Guide 2022
    Get our special report Multibagger Stocks Guide (2022 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Dec 7, 2021 11:38 AM